Becker's Healthcare March 1, 2022
Mackenzie Bean

Annual spending on pharmaceutical products has skyrocketed since 2010, though out-of-pocket costs have fallen, according to a Feb. 28 report from ValuePenguin.

The financial research and analysis website analyzed 2019 prescription drug spending data from the U.S. Bureau of Economic Analysis and the Kaiser Family Foundation, along with population data from the U.S. Census Bureau. 

Five report findings:

1. U.S. spending on prescription and over-the-counter medications hit $570 billion in 2020, up 77 percent from $322 billion in 2010.


Today's Sponsors

Institute for Healthcare Improvement
Crossover Health

Today's Sponsors

Patient Bond

Today's Sponsor


Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending, Survey / Study, Trends
Study: Many digital health startups lack clinical trials, regulatory filings
Mark Cuban's generic drug prices would save Medicare billions of dollars: Harvard study
Washington ups pressure on PBMs with more aggressive FTC policy, congressional ask for GAO study
$3 Billion in Cancer Drug Waste: Can It Be Salvaged?
Building a stronger opioid stewardship program that Includes drug diversion prevention